Maria Silvoniemi
marber@utu.fi |
- Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab (2025)
- Frontiers in Oncology
- Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis (2024)
- International Journal of Molecular Sciences
- Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study (2024)
- Cancers
- Taustatekijät vaikuttavat ALS-potilaiden saattohoitoon ja kuolinpaikkaan (2024)
- Lääkärilehti
- Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy (2023)
- Clinical Lung Cancer
- Feasibility and User Experience of Digital Patient Monitoring for Real-World Patients With Lung or Breast Cancer (2023)
- Oncologist
- Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study (2023)
- Acta Oncologica
- Trends in treatment of non-small cell lung cancer in Finland 2014-2019 (2022)
- Acta Oncologica
- Treatment Patterns and Outcomes in a Cohort of Finnish NSCLC Patients with ALK Rearrangement Reflect Rapid Evolution in Treatment Practices (2021)
- International Journal of Clinical and Experimental Medical Sciences
- Physicians’ views on palliative care and assessment of symptoms of non-small cell lung cancer patients (2018) Silvoniemi Maria
- Symptom Assessment for Patients with Non-small Cell Lung Cancer Scheduled for Chemotherapy (2016)
- Anticancer Research
- Opioids in pain management of mesothelioma and lung cancer patients (2013)
- Acta Oncologica
UTU Research Portal